263 related articles for article (PubMed ID: 36376318)
21. Human reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes.
Kim CY; Lee M; Yang S; Kim K; Yong D; Kim HR; Lee I
Genome Med; 2021 Aug; 13(1):134. PubMed ID: 34446072
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
23. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
[TBL] [Abstract][Full Text] [Related]
24. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
Kishikawa T; Maeda Y; Nii T; Motooka D; Matsumoto Y; Matsushita M; Matsuoka H; Yoshimura M; Kawada S; Teshigawara S; Oguro E; Okita Y; Kawamoto K; Higa S; Hirano T; Narazaki M; Ogata A; Saeki Y; Nakamura S; Inohara H; Kumanogoh A; Takeda K; Okada Y
Ann Rheum Dis; 2020 Jan; 79(1):103-111. PubMed ID: 31699813
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
26. Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China.
Mao L; Zhang Y; Tian J; Sang M; Zhang G; Zhou Y; Wang P
Front Microbiol; 2021; 12():728479. PubMed ID: 34650532
[TBL] [Abstract][Full Text] [Related]
27. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease.
Ilieva NM; Wallen ZD; De Miranda BR
Toxicol Appl Pharmacol; 2022 Sep; 451():116176. PubMed ID: 35914559
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
Wang S; Li N; Zou H; Wu M
Neurosci Lett; 2019 Mar; 696():93-98. PubMed ID: 30572101
[TBL] [Abstract][Full Text] [Related]
29. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
[TBL] [Abstract][Full Text] [Related]
30. Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.
Boertien JM; Pereira PAB; Aho VTE; Scheperjans F
J Parkinsons Dis; 2019; 9(s2):S297-S312. PubMed ID: 31498131
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
32. Alterations of the Gut Microbiome in Hypertension.
Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
[No Abstract] [Full Text] [Related]
33. Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing in the Study of Human Gut Microbiome.
Laudadio I; Fulci V; Palone F; Stronati L; Cucchiara S; Carissimi C
OMICS; 2018 Apr; 22(4):248-254. PubMed ID: 29652573
[TBL] [Abstract][Full Text] [Related]
34. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
[TBL] [Abstract][Full Text] [Related]
35. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
36. Perspective and Guidelines for Metaproteomics in Microbiome Studies.
Zhang X; Figeys D
J Proteome Res; 2019 Jun; 18(6):2370-2380. PubMed ID: 31009573
[TBL] [Abstract][Full Text] [Related]
37. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD
Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650
[TBL] [Abstract][Full Text] [Related]
38. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
39. Carnelian uncovers hidden functional patterns across diverse study populations from whole metagenome sequencing reads.
Nazeen S; Yu YW; Berger B
Genome Biol; 2020 Feb; 21(1):47. PubMed ID: 32093762
[TBL] [Abstract][Full Text] [Related]
40. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
